Skip to main content

Advertisement

SpringerLink
Log in

Konsolidierende Lokaltherapie beim oligometastasierten NSCLC ohne Progress nach Erstlinien-Chemotherapie

Consolidative local therapy in oligometastatic NSCLC without progression after first-line chemotherapy

  • Literatur kommentiert
  • Published:
Strahlentherapie und Onkologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Rusthoven KE, Hammerman SF, Kavanagh BD, Birtwhistle MJ, Stares M, Camidge DR (2009) Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patterns-of-failure analysis. Acta Oncol 48(4):578–583. doi:10.1080/02841860802662722

    Article  CAS  PubMed  Google Scholar 

  2. Gomez DR, Blumenschein GR Jr., Lee JJ, Hernandez M, Ye R, Camidge DR, Doebele RC, Skoulidis F, Gaspar LE, Gibbons DL, Karam JA, Kavanagh BD, Tang C, Komaki R, Louie AV, Palma DA, Tsao AS, Sepesi B, William WN, Zhang J, Shi Q, Wang XS, Swisher SG, Heymach JV (2016) Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study. Lancet Oncol 17(12):1672–1682. doi:10.1016/S1470-2045(16)30532-0

    Article  CAS  PubMed  Google Scholar 

  3. Inoue T, Katoh N, Aoyama H, Onimaru R, Taguchi H, Onodera S, Yamaguchi S, Shirato H (2010) Clinical outcomes of stereotactic brain and/or body radiotherapy for patients with oligometastatic lesions. Jpn J Clin Oncol 40(8):788–794. doi:10.1093/jjco/hyq044

    Article  PubMed  Google Scholar 

  4. Pfannschmidt J, Dienemann H (2010) Surgical treatment of oligometastatic non-small cell lung cancer. Lung Cancer 69(3):251–258. doi:10.1016/j.lungcan.2010.05.003

    Article  PubMed  Google Scholar 

  5. Khan AJ, Mehta PS, Zusag TW, Bonomi PD, Penfield Faber L, Shott S, Abrams RA (2006) Long term disease-free survival resulting from combined modality management of patients presenting with oligometastatic, non-small cell lung carcinoma (NSCLC). Radiother Oncol 81(2):163–167. doi:10.1016/j.radonc.2006.09.006

    Article  PubMed  Google Scholar 

  6. Sheu T, Heymach JV, Swisher SG, Rao G, Weinberg JS, Mehran R, McAleer MF, Liao Z, Aloia TA, Gomez DR (2014) Propensity score-matched analysis of comprehensive local therapy for oligometastatic non-small cell lung cancer that did not progress after front-line chemotherapy. Int J Radiat Oncol Biol Phys 90(4):850–857. doi:10.1016/j.ijrobp.2014.07.012

    Article  PubMed  Google Scholar 

  7. Tan CS, Gilligan D, Pacey S (2015) Treatment approaches for EGFR-inhibitor-resistant patients with non-small-cell lung cancer. Lancet Oncol 16(9):e447–e459. doi:10.1016/S1470-2045(15)00246-6

    Article  CAS  PubMed  Google Scholar 

  8. Rieber J, Streblow J, Uhlmann L, Flentje M, Duma M, Ernst I, Blanck O, Wittig A, Boda-Heggemann J, Krempien R, Lohaus F, Klass ND, Eble MJ, Imhoff D, Kahl H, Petersen C, Gerum S, Henkenberens C, Adebahr S, Hass P, Schrade E, Wendt TG, Hildebrandt G, Andratschke N, Sterzing F, Guckenberger M (2016) Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases – A pooled analysis of the German working group „stereotactic radiotherapy“. Lung Cancer 97:51–58. doi:10.1016/j.lungcan.2016.04.012

    Article  PubMed  Google Scholar 

  9. Boda-Heggemann J, Dinter D, Weiss C, Frauenfeld A, Siebenlist K, Attenberger U, Ottstadt M, Schneider F, Hofheinz RD, Wenz F, Lohr F (2012) Hypofractionated image-guided breath-hold SABR (stereotactic ablative body radiotherapy) of liver metastases – clinical results. Radiat Oncol 7:92. doi:10.1186/1748-717X-7-92

    Article  PubMed  PubMed Central  Google Scholar 

  10. Hellman S, Weichselbaum RR (1995) Oligometastases. J Clin Oncol 13(1):8–10. doi:10.1200/jco.1995.13.1.8

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Strahlentherapie und Radioonkologie, Medizinische Fakultät Mannheim, Universität Heidelberg, Theodor-Kutzer-Ufer 1–3, 68167, Mannheim, Deutschland

    Daniel Buergy MSc &  Frederik Wenz

Authors
  1. Daniel Buergy MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Frederik Wenz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Daniel Buergy MSc or Frederik Wenz.

Ethics declarations

Interessenkonflikt

D. Buergy und F. Wenz geben an, dass kein Interessenkonflikt besteht.

Additional information

Originalpublikation Gomez DR, Blumenschein GR, Lee JJ et al (2016) Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study. Lancet Oncol 17(12):1672–1682. doi: 10.1016/S1470-2045(16)30532-0

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Buergy, D., Wenz, F. Konsolidierende Lokaltherapie beim oligometastasierten NSCLC ohne Progress nach Erstlinien-Chemotherapie. Strahlenther Onkol 193, 341–343 (2017). https://doi.org/10.1007/s00066-017-1113-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00066-017-1113-1

Search

Navigation